They seem to be saying that types of Cancers evolve, similar to disease-causing bacteria that gradually become resistant to antibiotics. So a type of cancer – in this case Prostate Cancer – that historically has been pretty slow-moving can all of a sudden, nationwide, for no apparent reason, speed up?
Maybe this is old news and I haven’t been listening, but it seems pretty important in the context of the urgency of gaining widespread credibility & acceptance for natural medicines like Cannabis, Coca and Opium, especially since after over 50 years of the miracle cancer medicines created by Pig Pharma we now have the goddamned things speeding up!
Meanwhile people worldwide are telling the internet that they or somebody they love has been cured of Cancer by one Cannabis-based treatment or another – there are very fluid limits to Cannabis as a medicine and I suspect that we’re nowhere near them yet. And we’re not focusing at all in the US on the healing properties of pure Coca Leaf.
There is work to be done, and at least there are a lot of talented people doing it.
Anyone can find out the latest 2016 clinical and streetwise information with some quick searches, and NIH’s “PubMed” website is a great place to look for the clinical side of Cannabis health research.
To get you started here is a good summary of Cannabis Prostate research as of 2012 by the National Institutes of Health “PubMed” (there are later findings, but this is a good place to start if you haven’t been on PubMed yet):
“Prostate cancer is a global public health problem, and it is the most common cancer in American men and the second cause for cancer-related death. Experimental evidence shows that prostate tissue possesses cannabinoid receptors and their stimulation results in anti-androgenic effects. To review currently relevant findings related to effects of cannabinoid receptors in prostate cancer. PubMed search utilizing the terms “cannabis,” “cannabinoids,” “prostate cancer,” and “cancer pain management,” giving preference to most recent publications was done.”
“Articles identified were screened for their relevance to the field of prostate cancer and interest to both urologist and pain specialists.”
“Prostate cancer cells possess increased expression of both cannabinoid 1 and 2 receptors, and stimulation of these results in decrease in cell viability, increased apoptosis, and decreased androgen receptor expression and prostate-specific antigen excretion. It would be of interest to conduct clinical studies utilizing cannabinoids for patients with metastatic prostate cancer, taking advantage not only of its beneficial effects on prostate cancer but also of their analgesic properties for bone metastatic cancer pain.”